Cargando…

Atomoxetine restores the response inhibition network in Parkinson’s disease

Parkinson’s disease impairs the inhibition of responses, and whilst impulsivity is mild for some patients, severe impulse control disorders affect ∼10% of cases. Based on preclinical models we proposed that noradrenergic denervation contributes to the impairment of response inhibition, via changes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rae, Charlotte L., Nombela, Cristina, Rodríguez, Patricia Vázquez, Ye, Zheng, Hughes, Laura E., Jones, P. Simon, Ham, Timothy, Rittman, Timothy, Coyle-Gilchrist, Ian, Regenthal, Ralf, Sahakian, Barbara J., Barker, Roger A., Robbins, Trevor W., Rowe, James B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958901/ https://www.ncbi.nlm.nih.gov/pubmed/27343257 http://dx.doi.org/10.1093/brain/aww138

Ejemplares similares

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
por: Ye, Zheng, et al.
Publicado: (2016)

Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
por: Ye, Zheng, et al.
Publicado: (2015)

Targeting impulsivity in Parkinson’s disease using atomoxetine
por: Kehagia, Angie A., et al.
Publicado: (2014)

Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease
por: Borchert, Robin J, et al.
Publicado: (2016)

Atomoxetine and citalopram alter brain network organization in Parkinson’s disease
por: Borchert, Robin J, et al.
Publicado: (2019)

Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
por: Ye, Zheng, et al.
Publicado: (2014)

Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals
por: Passamonti, Luca, et al.
Publicado: (2017)

Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson’s disease
por: Zhang, Jiaxiang, et al.
Publicado: (2016)

Multiple Modes of Impulsivity in Parkinson's Disease
por: Nombela, Cristina, et al.
Publicado: (2014)

Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease
por: O’Callaghan, Claire, et al.
Publicado: (2021)

Improving response inhibition systems in frontotemporal dementia with citalopram
por: Hughes, Laura E., et al.
Publicado: (2015)

Managing cognition in progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

Towards accurate and unbiased imaging-based differentiation of Parkinson’s disease, progressive supranuclear palsy and corticobasal syndrome
por: Correia, Marta M, et al.
Publicado: (2020)

Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia
por: Hughes, Laura E, et al.
Publicado: (2018)

Neurophysiological signatures of Alzheimer’s disease and frontotemporal lobar degeneration: pathology versus phenotype
por: Sami, Saber, et al.
Publicado: (2018)

In Vivo Assay of Cortical Microcircuitry in Frontotemporal Dementia: A Platform for Experimental Medicine Studies
por: Shaw, Alexander D, et al.
Publicado: (2019)

Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants
por: Street, Duncan, et al.
Publicado: (2021)

Time on timing: Dissociating premature responding from interval sensitivity in Parkinson's disease
por: Zhang, Jiaxiang, et al.
Publicado: (2016)

Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers
por: Müller, U., et al.
Publicado: (2013)

Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes
por: Hezemans, Frank H., et al.
Publicado: (2022)

Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration
por: Lansdall, Claire J., et al.
Publicado: (2019)

How often does music and rhythm improve patients’ perception of motor symptoms in Parkinson’s disease?
por: Nombela, C., et al.
Publicado: (2013)

White matter pathology in Parkinson's disease: The effect of imaging protocol differences and relevance to executive function
por: Rae, Charlotte L., et al.
Publicado: (2012)

Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait
por: Revuelta, Gonzalo J., et al.
Publicado: (2015)

Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis
por: Kehagia, Angie A., et al.
Publicado: (2012)

Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans
por: Skandali, Nikolina, et al.
Publicado: (2018)

Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

The medial frontal-prefrontal network for altered awareness and control of action in corticobasal syndrome
por: Wolpe, Noham, et al.
Publicado: (2014)

Apathy and impulsivity in frontotemporal lobar degeneration syndromes
por: Lansdall, Claire J., et al.
Publicado: (2017)

Treatment of Children and Adolescents with Epilepsy with Atomoxetine
por: Park, Kee Jeong, et al.
Publicado: (2020)

Structural correlates of survival in Progressive Supranuclear Palsy
por: Street, Duncan, et al.
Publicado: (2023)

White matter change with apathy and impulsivity in frontotemporal lobar degeneration syndromes
por: Lansdall, Claire J., et al.
Publicado: (2018)

Progressive supranuclear palsy: diagnosis and management
por: Rowe, James B, et al.
Publicado: (2021)

Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
por: Winder-Rhodes, Sophie E., et al.
Publicado: (2015)

A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015)

Off-label use of atomoxetine in adults: is it safe?
por: Dadashova, Rana, et al.
Publicado: (2012)

Atomoxetine in abstinent cocaine users: Sex differences
por: DeVito, Elise E., et al.
Publicado: (2017)

The effect of atomoxetine on random and directed exploration in humans
por: Warren, Christopher M., et al.
Publicado: (2017)

Dopaminergic modulation of positive expectations for goal-directed action: evidence from Parkinson’s disease
por: Wolpe, Noham, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lkd1ufjqcb16au28jqtf7magla